Is IRadimed Corporation (IRMD) a Buy, Sell, or Hold?
NASDAQ : IRMD
IRadimed Corporation — News
$92.495 USD
$1.28 (1.41%)
- Volume
- 87.46K
- Average Volume
- 134.76K
- Market Capitalization
- $1.18B
- P/E Ratio
- 50.82
- Dividend Yield
- 1.34%
- Price Target
- $120.00
- Year High
- $107.90
- Year Low
- $67.84
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.69
- Current Ratio
- $9.46
| Source | Headline |
|---|---|
|
iRadimed Q2 Earnings Call Highlights
iRadimed NASDAQ: IRMD reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked through the costs associated with an initial manufacturing ramp. marketbeat.com - 2026-07-31 13:05:37 |
|
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-07-31 12:43:16 |
|
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by $0.1 million, or 0.5% compared to the same period in 2025. Reports GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46 for the second quarter of 2026. globenewswire.com - 2026-07-31 08:15:00 |
|
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. globenewswire.com - 2026-07-24 16:15:00 |
|
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
This medical device maker, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year stock performance. fool.com - 2026-06-02 08:09:44 |
|
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida. globenewswire.com - 2026-05-20 08:30:00 |
